Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study
Sign Up to like & getrecommendations! Published in 2019 at "Infectious Diseases and Therapy"
DOI: 10.1007/s40121-019-00274-5
Abstract: Introduction Dolutegravir (DTG), Elvitegravir (EVG), Raltegravir (RAL) and Darunavir (DRV) are commonly prescribed core agents for antiretroviral therapy (ART), and a need exists to compare their clinical effectiveness, as defined by virologic failure risks in… read more here.
Keywords: ral drv; dtg; virologic failure; drv ... See more keywords